Page last updated: 2024-11-03

procarbazine and Minimal Disease, Residual

procarbazine has been researched along with Minimal Disease, Residual in 8 studies

Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.

Research Excerpts

ExcerptRelevanceReference
"Based on the treatment results of 300 Hodgkin lymphoma patients the authors formulated the basic approaches for radiation treatment in ABVD and BEACOPP-21 chemotherapy regimens recipients."1.38[The optimal total focal radiotherapy dosage after first-line chemotherapy in patients with Hodgkin lymphoma]. ( Datsenko, PV; Evstikheev, ÉV; Golub, SV; Gombolevskiĭ, VA; Ivashin, AV; Pan'shin, GA; Sotnikov, VM, 2012)
"Of the 13 children with a residual tumour, chemotherapy induced 2 partial responses (PR), 1 minor response (MR) and 1 stable disease (SD) with no recurrent disease."1.33High-grade glioma in children under 5 years of age: a chemotherapy only approach with the BBSFOP protocol. ( Chastagner, P; Doz, F; Dufour, C; Frappaz, D; Gentet, JC; Grill, J; Kalifa, C; Lellouch-Tubiana, A; Pichon, F; Plantaz, D; Puget, S; Raquin, MA, 2006)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's4 (50.00)29.6817
2010's3 (37.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Datsenko, PV1
Pan'shin, GA1
Sotnikov, VM1
Ivashin, AV1
Evstikheev, ÉV1
Golub, SV1
Gombolevskiĭ, VA1
Kriz, J2
Reinartz, G1
Dietlein, M2
Kobe, C2
Kuhnert, G1
Haverkamp, H1
Haverkamp, U1
Engenhart-Cabillic, R1
Herfarth, K1
Lukas, P1
Schmidberger, H1
Staar, S2
Hegerfeld, K1
Baues, C1
Engert, A3
Eich, HT3
Vigneron, C1
Antoni, D1
Coca, A1
Entz-Werlé, N1
Lutz, P1
Spiegel, A1
Jannier, S1
Niederst, C1
Jarnet, D1
Meyer, P1
Kehrli, P1
Noël, G1
Franklin, J1
Markova, J1
Lohri, A1
Amthauer, H1
Klutmann, S1
Knapp, WH1
Zijlstra, JM1
Bockisch, A1
Weckesser, M1
Lorenz, R1
Schreckenberger, M1
Bares, R1
Mueller, RP1
Fuchs, M1
Borchmann, P1
Schicha, H1
Diehl, V2
Chintagumpala, MM1
Friedman, HS1
Stewart, CF1
Kepner, J1
McLendon, RE1
Modrich, PL1
McCluggage, C1
Burger, P1
Holmes, E1
Thompson, S1
Rutka, J1
Michalski, J1
Woo, S1
Blaney, SM1
Kun, LE1
Horowitz, ME1
Dufour, C1
Grill, J1
Lellouch-Tubiana, A1
Puget, S1
Chastagner, P1
Frappaz, D1
Doz, F1
Pichon, F1
Plantaz, D1
Gentet, JC1
Raquin, MA1
Kalifa, C1
Gossmann, A1
Bredenfeld, H1
Hansemann, K1
Skripnitchenko, R1
Brillant, C1
Pfistner, B1
Müller, RP1
Redei, I1
Mangan, KF1
Ming, PL1
Mullaney, MT1
Rao, PN1
Goldberg, SL1
Klumpp, TR1

Trials

4 trials available for procarbazine and Minimal Disease, Residual

ArticleYear
Relapse analysis of irradiated patients within the HD15 trial of the German Hodgkin Study Group.
    International journal of radiation oncology, biology, physics, 2015, May-01, Volume: 92, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cycloph

2015
Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma.
    Blood, 2008, Nov-15, Volume: 112, Issue:10

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dise

2008
A phase II window trial of procarbazine and topotecan in children with high-grade glioma: a report from the children's oncology group.
    Journal of neuro-oncology, 2006, Volume: 77, Issue:2

    Topics: Adaptor Proteins, Signal Transducing; Adolescent; Adult; Alkyl and Aryl Transferases; Antineoplastic

2006
A Contribution to solve the problem of the need for consolidative radiotherapy after intensive chemotherapy in advanced stages of Hodgkin's lymphoma--analysis of a quality control program initiated by the radiotherapy reference center of the German Hodgki
    International journal of radiation oncology, biology, physics, 2007, Nov-15, Volume: 69, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit

2007

Other Studies

4 other studies available for procarbazine and Minimal Disease, Residual

ArticleYear
[The optimal total focal radiotherapy dosage after first-line chemotherapy in patients with Hodgkin lymphoma].
    Voprosy onkologii, 2012, Volume: 58, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazin

2012
[Pediatric medulloblastoma: Retrospective series of 52 patients].
    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2016, Volume: 20, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Chemotherapy, Adju

2016
High-grade glioma in children under 5 years of age: a chemotherapy only approach with the BBSFOP protocol.
    European journal of cancer (Oxford, England : 1990), 2006, Volume: 42, Issue:17

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child, Preschool; Cisp

2006
Detection of a dormant 20q- leukemia clone in bone marrow cultures with hematopoietic growth factors: implications for secondary leukemia post-transplant.
    Bone marrow transplantation, 1997, Volume: 19, Issue:5

    Topics: Acute Disease; Adult; Anemia, Refractory, with Excess of Blasts; Antimetabolites, Antineoplastic; An

1997
chemdatabank.com